Neurobiological Correlates of Alpha-Tocopherol Antiepileptogenic Effects and MicroRNA Expression Modulation in a Rat Model of Kainate-Induced Seizures.

Patrizia Ambrogini, Maria Cristina Albertini, Michele Betti, Claudia Galati, Davide Lattanzi, David Savelli, Michael Di Palma, Stefania Saccomanno, Desirée Bartolini, Pierangelo Torquato, Gabriele Ruffolo, Fabiola Olivieri, Francesco Galli, Eleonora Palma, Andrea Minelli, Riccardo Cuppini
Author Information
  1. Patrizia Ambrogini: Department of Biomolecular Sciences, Section of Physiology, University of Urbino Carlo Bo, I-61029, Urbino, Italy. patrizia.ambrogini@uniurb.it. ORCID
  2. Maria Cristina Albertini: Department of Biomolecular Sciences, Section of Physiology, University of Urbino Carlo Bo, I-61029, Urbino, Italy.
  3. Michele Betti: Department of Biomolecular Sciences, Section of Physiology, University of Urbino Carlo Bo, I-61029, Urbino, Italy.
  4. Claudia Galati: Department of Biomolecular Sciences, Section of Physiology, University of Urbino Carlo Bo, I-61029, Urbino, Italy.
  5. Davide Lattanzi: Department of Biomolecular Sciences, Section of Physiology, University of Urbino Carlo Bo, I-61029, Urbino, Italy.
  6. David Savelli: Department of Biomolecular Sciences, Section of Physiology, University of Urbino Carlo Bo, I-61029, Urbino, Italy.
  7. Michael Di Palma: Department of Biomolecular Sciences, Section of Physiology, University of Urbino Carlo Bo, I-61029, Urbino, Italy.
  8. Stefania Saccomanno: Department of Gastroenterology, Marche Polytechnic University, Ancona, Italy.
  9. Desirée Bartolini: Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy.
  10. Pierangelo Torquato: Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy.
  11. Gabriele Ruffolo: Department of Physiology and Pharmacology, University of Rome Sapienza, Rome, Italy.
  12. Fabiola Olivieri: Department of Molecular and Clinical Sciences, Marche Polytechnic University, Ancona, Italy.
  13. Francesco Galli: Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy.
  14. Eleonora Palma: Department of Physiology and Pharmacology, University of Rome Sapienza, Rome, Italy.
  15. Andrea Minelli: Department of Biomolecular Sciences, Section of Physiology, University of Urbino Carlo Bo, I-61029, Urbino, Italy.
  16. Riccardo Cuppini: Department of Biomolecular Sciences, Section of Physiology, University of Urbino Carlo Bo, I-61029, Urbino, Italy.

Abstract

Seizure-triggered maladaptive neural plasticity and neuroinflammation occur during the latent period as a key underlying event in epilepsy chronicization. Previously, we showed that α-tocopherol (α-T) reduces hippocampal neuroglial activation and neurodegeneration in the rat model of kainic acid (KA)-induced status epilepticus (SE). These findings allowed us to postulate an antiepileptogenic potential for α-T in hippocampal excitotoxicity, in line with clinical evidence showing that α-T improves seizure control in drug-resistant patients. To explore neurobiological correlates of the α-T antiepileptogenic role, rats were injected with such vitamin during the latent period starting right after KA-induced SE, and the effects on circuitry excitability, neuroinflammation, neuronal death, and microRNA (miRNA) expression were investigated in the hippocampus. Results show that in α-T-treated epileptic rats, (1) the number of population spikes elicited by pyramidal neurons, as well as the latency to the onset of epileptiform-like network activity recover to control levels; (2) neuronal death is almost prevented; (3) down-regulation of claudin, a blood-brain barrier protein, is fully reversed; (4) neuroinflammation processes are quenched (as indicated by the decrease of TNF-α, IL-1β, GFAP, IBA-1, and increase of IL-6); (5) miR-146a, miR-124, and miR-126 expression is coherently modulated in hippocampus and serum by α-T. These findings support the potential of a timely intervention with α-T in clinical management of SE to reduce epileptogenesis, thus preventing chronic epilepsy development. In addition, we suggest that the analysis of miRNA levels in serum could provide clinicians with a tool to evaluate disease evolution and the efficacy of α-T therapy in SE.

Keywords

References

  1. J Immunol. 1989 Dec 1;143(11):3517-23 [PMID: 2584704]
  2. Epilepsy Behav. 2011 Dec;22(4):678-84 [PMID: 22056341]
  3. Glia. 2017 Jan;65(1):5-18 [PMID: 27189853]
  4. Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10183-8 [PMID: 15218107]
  5. Neurotoxicology. 2008 Jul;29(4):621-7 [PMID: 18556069]
  6. J Physiol. 2012 Nov 15;590(22):5707-22 [PMID: 22988138]
  7. Neurochem Res. 2010 Apr;35(4):580-7 [PMID: 19941068]
  8. Neurobiol Dis. 2017 Mar;99:12-23 [PMID: 27939857]
  9. Neuroscience. 2001;102(4):805-18 [PMID: 11182244]
  10. Neurobiol Dis. 2015 Oct;82:311-320 [PMID: 26168875]
  11. Brain Res. 2009 Jul 28;1282:162-72 [PMID: 19501063]
  12. Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6 [PMID: 16885212]
  13. Neurochem Res. 2009 Dec;34(12):2181-91 [PMID: 19513830]
  14. J Neurosci. 2008 Jul 2;28(27):6904-13 [PMID: 18596165]
  15. Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):504-9 [PMID: 24344272]
  16. Neuroscience. 2013 Feb 12;231:195-205 [PMID: 23238573]
  17. Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii50-5 [PMID: 19022814]
  18. Electroencephalogr Clin Neurophysiol. 1982 Jun;53(6):581-9 [PMID: 6177503]
  19. Synapse. 1989;3(2):154-71 [PMID: 2648633]
  20. Mol Neurobiol. 2014 Aug;50(1):246-56 [PMID: 24488645]
  21. Semin Cell Dev Biol. 2015 Feb;38:26-34 [PMID: 25444846]
  22. Epilepsia. 2005 Apr;46(4):470-2 [PMID: 15816939]
  23. Blood. 1993 Apr 15;81(8):2076-84 [PMID: 8386026]
  24. Epilepsia. 2004 Jun;45(6):695-714 [PMID: 15144438]
  25. Epilepsy Res. 2005 Aug-Sep;66(1-3):185-94 [PMID: 16162400]
  26. Eur J Neurosci. 2010 Mar;31(6):1100-7 [PMID: 20214679]
  27. Mech Ageing Dev. 2012 Nov-Dec;133(11-12):675-85 [PMID: 23041385]
  28. CNS Neurol Disord Drug Targets. 2015;14(2):157-67 [PMID: 25613507]
  29. Brain Res. 1974 Sep 13;77(3):507-12 [PMID: 4152936]
  30. PLoS One. 2012;7(9):e44789 [PMID: 23028621]
  31. Zh Nevropatol Psikhiatr Im S S Korsakova. 1984;84(6):892-7 [PMID: 6431729]
  32. Exp Neurol. 2012 Jun;235(2):427-35 [PMID: 22178324]
  33. Cell Res. 2008 Oct;18(10):997-1006 [PMID: 18766170]
  34. Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20944-8 [PMID: 18083839]
  35. Hippocampus. 2016 Mar;26(3):341-61 [PMID: 26333017]
  36. Molecules. 2010 Mar 12;15(3):1746-61 [PMID: 20336011]
  37. Pharmacol Biochem Behav. 2004 Apr;77(4):761-6 [PMID: 15099921]
  38. J Cereb Blood Flow Metab. 2000 Jun;20(6):956-66 [PMID: 10894179]
  39. Mol Pharmacol. 2009 Oct;76(4):884-95 [PMID: 19620254]
  40. J Neurobiol. 2006 Jul;66(8):793-810 [PMID: 16673395]
  41. Int J Endocrinol. 2017;2017:4357080 [PMID: 28396684]
  42. Neuropsychopharmacology. 2001 Jan;24(1):86-96 [PMID: 11106879]
  43. Ann Neurol. 1992 Nov;32(5):618-24 [PMID: 1449242]
  44. Eur J Neurosci. 2000 Jul;12(7):2623-33 [PMID: 10947836]
  45. Lancet Neurol. 2011 Feb;10(2):173-86 [PMID: 21256455]
  46. Inflammation. 2014 Feb;37(1):71-82 [PMID: 23974950]
  47. J Neurosci Res. 2003 Aug 15;73(4):447-55 [PMID: 12898529]
  48. Brain Res. 1985 Dec 30;361(1-2):389-91 [PMID: 4084805]
  49. Dev Cell. 2008 Aug;15(2):261-71 [PMID: 18694565]
  50. Nat Rev Neurosci. 2013 May;14(5):337-49 [PMID: 23595016]
  51. Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94 [PMID: 4110397]
  52. Epilepsy Res. 2009 Apr;84(2-3):232-7 [PMID: 19261443]
  53. Dev Cell. 2008 Aug;15(2):272-84 [PMID: 18694566]
  54. eNeuro. 2017 Jan 16;3(6): [PMID: 28101527]
  55. Neurology. 1998 Nov;51(5):1243-4 [PMID: 9818838]
  56. Biofactors. 2010 Jan-Feb;36(1):33-42 [PMID: 20108329]
  57. PLoS One. 2011 Jan 27;6(1):e16617 [PMID: 21304604]
  58. Front Cell Neurosci. 2015 May 20;9:193 [PMID: 26041995]
  59. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1516-21 [PMID: 18227515]
  60. Pharmacol Biochem Behav. 2002 Jan-Feb;71(1-2):245-9 [PMID: 11812529]
  61. Int J Mol Sci. 2016 Dec 15;17(12): [PMID: 27983697]
  62. Methods Mol Biol. 2006;322:347-55 [PMID: 16739735]
  63. Epilepsia. 1999 Sep;40(9):1210-21 [PMID: 10487183]
  64. Brain Res. 2004 Aug 13;1017(1-2):21-31 [PMID: 15261095]
  65. Neurosci Lett. 2001 May 11;303(3):198-200 [PMID: 11323119]
  66. Sci Rep. 2016 Dec 06;6:38242 [PMID: 27922053]
  67. Neurobiol Dis. 2016 Nov;95:93-101 [PMID: 27425893]
  68. Sci Rep. 2014 Apr 22;4:4734 [PMID: 24751812]
  69. Epilepsia. 2002 Jul;43(7):703-10 [PMID: 12102672]
  70. J Physiol. 1997 Dec 15;505 ( Pt 3):655-63 [PMID: 9457643]
  71. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Apr 15;1019:178-90 [PMID: 26706659]
  72. Ann Neurol. 2004 Jul;56(1):164-5; author reply 165-6 [PMID: 15236418]
  73. Nat Cell Biol. 2009 Jul;11(7):873-80 [PMID: 19503073]
  74. Exp Gerontol. 2013 Dec;48(12):1428-35 [PMID: 24113154]
  75. Brain Res. 1994 Apr 18;643(1-2):173-80 [PMID: 7913397]
  76. Adv Exp Med Biol. 2014;813:xv-xviii [PMID: 25371938]
  77. Biochim Biophys Acta. 2011 May;1813(5):878-88 [PMID: 21296109]
  78. Epilepsia. 2013 Oct;54(10):1834-44 [PMID: 24032743]
  79. Neuroscience. 2014 Feb 28;260:120-9 [PMID: 24342566]
  80. J Mol Cell Biol. 2011 Jun;3(3):159-66 [PMID: 21502305]
  81. Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3180-5 [PMID: 20133704]
  82. Eur Neurol. 2007;57(2):65-9 [PMID: 17179706]
  83. Epilepsia. 2007 Oct;48(10):1842-9 [PMID: 17521347]
  84. J Neurophysiol. 1992 Dec;68(6):2120-7 [PMID: 1491262]
  85. Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13238-42 [PMID: 12237406]
  86. Free Radic Biol Med. 2006 Aug 1;41(3):464-72 [PMID: 16843827]
  87. Brain Res. 2014 Oct 10;1584:94-104 [PMID: 24096213]
  88. J Neurophysiol. 1999 Nov;82(5):2130-42 [PMID: 10561393]
  89. Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1667-72 [PMID: 15665077]
  90. Cell Rep. 2016 Mar 15;14(10):2402-12 [PMID: 26947066]
  91. Proc Natl Acad Sci U S A. 2006 May 30;103(22):8465-8 [PMID: 16709666]
  92. Free Radic Biol Med. 2017 Jan;102:16-36 [PMID: 27816611]
  93. Endocr Metab Immune Disord Drug Targets. 2014;14(4):283-9 [PMID: 25244230]
  94. Epilepsy Curr. 2008 May-Jun;8(3):68-72 [PMID: 18488058]
  95. Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15219-23 [PMID: 16217016]
  96. Nutrients. 2013 Oct 31;5(11):4347-63 [PMID: 24184873]
  97. Prog Neurobiol. 2009 May;88(1):32-40 [PMID: 19428960]
  98. Cell Stem Cell. 2007 Nov;1(5):515-28 [PMID: 18371391]
  99. Epilepsia. 1970 Mar;11(1):73-80 [PMID: 4987162]
  100. Brain Res Mol Brain Res. 2003 Feb 20;110(2):253-60 [PMID: 12591161]
  101. Neurochem Res. 2011 Nov;36(11):2195-204 [PMID: 21751034]
  102. Epilepsia. 2016 Sep;57(9):e191-4 [PMID: 27381590]
  103. Adv Biomed Res. 2016 Mar 16;5:36 [PMID: 27099849]

MeSH Term

Animals
Blood-Brain Barrier
Disease Models, Animal
Gene Expression Regulation
Inflammation
Kainic Acid
Male
MicroRNAs
Nerve Degeneration
Oocytes
Oxidative Stress
Rats, Sprague-Dawley
Receptors, GABA
Seizures
Status Epilepticus
Xenopus
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
alpha-Tocopherol

Chemicals

MicroRNAs
Receptors, GABA
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
alpha-Tocopherol
Kainic Acid

Word Cloud

Created with Highcharts 10.0.0α-TSEneuroinflammationlatentperiodepilepsyhippocampalfindingsantiepileptogenicpotentialclinicalcontrolratsneuronaldeathmiRNAexpressionhippocampuslevelsserumMicroRNASeizure-triggeredmaladaptiveneuralplasticityoccurkeyunderlyingeventchronicizationPreviouslyshowedα-tocopherolreducesneuroglialactivationneurodegenerationratmodelkainicacidKA-inducedstatusepilepticusalloweduspostulateexcitotoxicitylineevidenceshowingimprovesseizuredrug-resistantpatientsexploreneurobiologicalcorrelatesroleinjectedvitaminstartingrightKA-inducedeffectscircuitryexcitabilitymicroRNAinvestigatedResultsshowα-T-treatedepileptic1numberpopulationspikeselicitedpyramidalneuronswelllatencyonsetepileptiform-likenetworkactivityrecover2almostprevented3down-regulationclaudinblood-brainbarrierproteinfullyreversed4processesquenchedindicateddecreaseTNF-αIL-1βGFAPIBA-1increaseIL-65miR-146amiR-124miR-126coherentlymodulatedsupporttimelyinterventionmanagementreduceepileptogenesisthuspreventingchronicdevelopmentadditionsuggestanalysisprovideclinicianstoolevaluatediseaseevolutionefficacytherapyNeurobiologicalCorrelatesAlpha-TocopherolAntiepileptogenicEffectsExpressionModulationRatModelKainate-InducedSeizuresEpilepsyNeuroprotectionSpontaneousrecurrentseizuresVitaminE

Similar Articles

Cited By